FR2956583B1 - USE OF INGREDIENT NEUTRALIZING COMPOSITION FOR TREATING APHTES - Google Patents

USE OF INGREDIENT NEUTRALIZING COMPOSITION FOR TREATING APHTES

Info

Publication number
FR2956583B1
FR2956583B1 FR1051241A FR1051241A FR2956583B1 FR 2956583 B1 FR2956583 B1 FR 2956583B1 FR 1051241 A FR1051241 A FR 1051241A FR 1051241 A FR1051241 A FR 1051241A FR 2956583 B1 FR2956583 B1 FR 2956583B1
Authority
FR
France
Prior art keywords
aphtes
ingredient
treating
neutralizing composition
neutralizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1051241A
Other languages
French (fr)
Other versions
FR2956583A1 (en
Inventor
Bertrand Girin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PREVIZEN
Original Assignee
PREVIZEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PREVIZEN filed Critical PREVIZEN
Priority to FR1051241A priority Critical patent/FR2956583B1/en
Priority to PCT/FR2011/050338 priority patent/WO2011101600A1/en
Publication of FR2956583A1 publication Critical patent/FR2956583A1/en
Application granted granted Critical
Publication of FR2956583B1 publication Critical patent/FR2956583B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
FR1051241A 2010-02-22 2010-02-22 USE OF INGREDIENT NEUTRALIZING COMPOSITION FOR TREATING APHTES Expired - Fee Related FR2956583B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1051241A FR2956583B1 (en) 2010-02-22 2010-02-22 USE OF INGREDIENT NEUTRALIZING COMPOSITION FOR TREATING APHTES
PCT/FR2011/050338 WO2011101600A1 (en) 2010-02-22 2011-02-17 Use of a neutralising composition by ingestion to treat or prevent the appearance of aphthas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1051241A FR2956583B1 (en) 2010-02-22 2010-02-22 USE OF INGREDIENT NEUTRALIZING COMPOSITION FOR TREATING APHTES

Publications (2)

Publication Number Publication Date
FR2956583A1 FR2956583A1 (en) 2011-08-26
FR2956583B1 true FR2956583B1 (en) 2012-12-21

Family

ID=42341486

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1051241A Expired - Fee Related FR2956583B1 (en) 2010-02-22 2010-02-22 USE OF INGREDIENT NEUTRALIZING COMPOSITION FOR TREATING APHTES

Country Status (2)

Country Link
FR (1) FR2956583B1 (en)
WO (1) WO2011101600A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250168A (en) * 1979-07-13 1981-02-10 Crawford Horace R Cold sore treatment method
EP1133244A4 (en) * 1998-11-25 2002-04-17 William F Aftoora Liquefied water soluble acidity-reducing formulation for food and beverage products
ES2186569B1 (en) * 2001-09-28 2004-09-16 Lacer, S.A. COMPOSITIONS FOR THE RELIEF OF XEROSTOMY AND THE TREATMENT OF DISORDERS ASSOCIATED WITH THE SAME.
JP3977724B2 (en) * 2001-11-06 2007-09-19 ロート製薬株式会社 Pharmaceutical composition
JP4799957B2 (en) * 2005-08-23 2011-10-26 興和株式会社 Pharmaceutical composition for the treatment of stomatitis
CN1824131B (en) * 2005-12-20 2011-12-28 博安兄弟制药（中国）有限公司 Weibimei medicical composition for treating stomach disease

Also Published As

Publication number Publication date
FR2956583A1 (en) 2011-08-26
WO2011101600A1 (en) 2011-08-25

Similar Documents

Publication Publication Date Title
ZA201301329B (en) Novel compounds and compositions for the inhibition of nampt
EP2552203A4 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
SMT201400055B (en) Thioacetate compounds, compositions and methods of use
HK1199220A1 (en) Pharmaceutical composition for the prevention or treatment of non- alcoholic fatty liver disease
EA201590165A1 (en) CONTAINING ABUSE OF PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED LIBERATION
FR2957254B1 (en) FLUID COMPOSITIONS FOR IMPROVING SKIN CONDITIONS
BR112013010157A2 (en) ibat inhibitors for the treatment of liver disease
BR112012021374A2 (en) "platform of thrown legs"
IL220939A (en) Compounds for the inhibition of hdac and pharmaceutical compositions comprising them
LU91805B1 (en) Virus inhibitory compositions for therapeutic use in vivo
CL2013001947A1 (en) Pharmaceutical composition comprising pioglitazone; use of pioglitazone to treat Alzheimer's; composition comprising pioglitazone.
BR112013000705A2 (en) "cleaning composition for personal care"
FR2988609B1 (en) FORMULATION FOR HORMONOTHERAPY
FR2962650B1 (en) COMPOSITION OF HUMAN CONCENTRATED IMMUNOGLOBULINS
DK2557924T3 (en) DERMAL PHARMACEUTICAL COMPOSITIONS OF 1-METHYL-2 ', 6'-PIPECOLOXYLIDEIDE AND PROCEDURE FOR THEIR USE
BR112013010684A2 (en) "liquid surfactant composition"
EA201270728A1 (en) PURINE CONNECTIONS
FR2965705B1 (en) SULFURANT COMPOSITIONS
FR2961107B1 (en) HUMAN IMMUNOGLOBULIN COMPOSITION STABILIZED
HK1208809A1 (en) Compositions and methods for enhancing the efficacy of contraceptive microbicides
FR2992861B1 (en) USE OF THIOSULFATE FOR POTENTIATING THE ANTI-PATHOGENIC EFFECT OF LACTOBACILLES
FR2961803B1 (en) ACID COMPOSITIONS FOR THE REMOVAL OF OXALATES
IT1402654B1 (en) COMPOSITION FOR THE RELEASE OF ACTIVE PRINCIPLES FROM PLANT DEVICES
EP2588080A4 (en) Injectable pharmaceutical compositions for the treatment of joints
BRPI0914139A2 (en) Pediatric compositions for the treatment of multiple sclerosis

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20221005